IRIDEX Future Growth
Future criteria checks 0/6
IRIDEX is forecast to grow earnings and revenue by 35.1% and 1.9% per annum respectively while EPS is expected to grow by 36.2% per annum.
Key information
35.1%
Earnings growth rate
36.2%
EPS growth rate
Medical Equipment earnings growth | 16.1% |
Revenue growth rate | 1.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 26 Mar 2024 |
Recent future growth updates
Recent updates
Iridex's Strategic Review Process Should Bear Fruit 'Soon'
Mar 28Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues
Feb 14Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?
Oct 04Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop
Aug 12Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?
Apr 14We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely
Oct 12Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?
Feb 25Iridex To Benefit From New Revolutionary Glaucoma Treatment
Jan 11Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long
Jan 03IRIDEX says laser therapy now accepted in the European Glaucoma Society guidelines
Dec 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 54 | -5 | N/A | N/A | 1 |
12/31/2024 | 52 | -6 | N/A | N/A | 1 |
12/30/2023 | 52 | -10 | -7 | -7 | N/A |
9/30/2023 | 55 | -8 | -8 | -7 | N/A |
7/1/2023 | 56 | -8 | -8 | -8 | N/A |
4/1/2023 | 57 | -7 | -9 | -9 | N/A |
12/31/2022 | 57 | -8 | -10 | -10 | N/A |
10/1/2022 | 57 | -9 | -10 | -10 | N/A |
7/2/2022 | 56 | -9 | -8 | -8 | N/A |
4/2/2022 | 55 | -6 | -7 | -7 | N/A |
1/1/2022 | 54 | -5 | 8 | 8 | N/A |
10/2/2021 | 51 | -3 | 10 | 10 | N/A |
7/3/2021 | 46 | -3 | 11 | 11 | N/A |
4/3/2021 | 39 | -7 | 10 | 10 | N/A |
1/2/2021 | 36 | -6 | -3 | -3 | N/A |
9/26/2020 | 36 | -8 | -3 | -3 | N/A |
6/27/2020 | 38 | -8 | -6 | -6 | N/A |
3/28/2020 | 42 | -7 | -6 | -6 | N/A |
12/28/2019 | 43 | -9 | -8 | -8 | N/A |
9/28/2019 | 43 | -10 | -10 | -10 | N/A |
6/29/2019 | 44 | -11 | -10 | -10 | N/A |
3/30/2019 | 44 | -12 | -11 | -11 | N/A |
12/29/2018 | 43 | -13 | -10 | -10 | N/A |
9/29/2018 | 41 | -15 | -9 | -9 | N/A |
6/30/2018 | 41 | -15 | -8 | -8 | N/A |
3/31/2018 | 41 | -15 | -5 | -5 | N/A |
12/30/2017 | 42 | -13 | -4 | -4 | N/A |
9/30/2017 | 44 | -19 | N/A | -3 | N/A |
7/1/2017 | 43 | -16 | N/A | -3 | N/A |
4/1/2017 | 45 | -14 | N/A | -2 | N/A |
12/31/2016 | 46 | -12 | N/A | 0 | N/A |
10/1/2016 | 46 | 0 | N/A | 0 | N/A |
7/2/2016 | 46 | 1 | N/A | 1 | N/A |
4/2/2016 | 43 | 0 | N/A | -1 | N/A |
1/2/2016 | 42 | 0 | N/A | -1 | N/A |
10/3/2015 | 41 | 9 | N/A | 1 | N/A |
7/4/2015 | 42 | 9 | N/A | 3 | N/A |
4/4/2015 | 43 | 10 | N/A | 4 | N/A |
1/3/2015 | 43 | 10 | N/A | 4 | N/A |
9/27/2014 | 42 | 2 | N/A | 2 | N/A |
6/28/2014 | 41 | 2 | N/A | 2 | N/A |
3/29/2014 | 40 | 2 | N/A | 2 | N/A |
12/28/2013 | 38 | 2 | N/A | 1 | N/A |
9/28/2013 | 37 | 2 | N/A | 2 | N/A |
6/29/2013 | 35 | 1 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IRIX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IRIX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IRIX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IRIX's revenue (1.9% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: IRIX's revenue (1.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IRIX's Return on Equity is forecast to be high in 3 years time